Formulation Supplied at 0.5 mg/ml in Tris saline, 0.02% sodium azide, pH7.3 with 0.5% bovine serum albumin.
| |
Unit Size 100 µg | |
Storage Instructions Aliquot and store at -20°C. Minimize freezing and thawing. | |
Synonym / Alias Names protein tyrosine phosphatase type IVA protein 1|DKFZp779M0721|RP5-1148A21.2|Protein tyrosine phosphatase IVA1|protein tyrosine phosphatase type IVA, member 1|PTP(CAAX1)|PTPCAAX1|PRL-1|PRL1|HH72|PTP4A1 | |
Usage Summary Immunofluorescence: Strong expression of the protein seen in HeLa and NIH3T3 cells. Recommended concentration: 10µg/ml.
Additional validation: This antibody has been successfully used in the following paper: Achiwa H et al. (2007) PMID: 17234774. | |
Accession ID NP_003454.1 | |
Blocking Peptide EBP06456 | |
Immunogen Peptide with sequence CFKDSNGHRNN, from the C Terminus of the protein sequence according to NP_003454.1. | |
Peptide Sequence CFKDSNGHRNN | |
Purification Method Purified from goat serum by ammonium sulphate precipitation followed by antigen affinity chromatography using the immunizing peptide. | |
Shipping Instructions Refrigerated | |
Predicted Species Human, Mouse, Rat, Dog | |
Reactive Species Human, Mouse | |
Human Gene ID 7803 | |
Product Grade  | |
ELISA Detection Limit Antibody detection limit dilution 1:64000. | |
Western Blot This antibody has been successfully used in Western Blot as descibed in the following papers, PMID: 18997816 and PMID: 36793871. | |
Application Type Pep-ELISA, WB, IF |
Goat Anti-PRL1 / PTP4A1 Antibody
$423.00
| SKU | Unit Size | Price |
|---|---|---|
Select a unit size:
Selected References [{"pmid": 17234774, "intro": "This antibody has been successfully used in the following paper:", "title": "PRL-1 tyrosine phosphatase regulates c-Src levels, adherence, and invasion in human lung cancer cells.", "author": "Achiwa H, Lazo JS.", "journal": "Cancer Res. 2007 Jan 15;67(2):643-50."}, {"pmid": 36793871, "intro": "This antibody has been successfully used in WB on Mouse:", "title": "Hepatic PTP4A1 ameliorates high-fat diet-induced hepatosteatosis and hyperglycemia by the activation of the CREBH/FGF21 axis.", "author": "Byungtae Hwang, Min-Gi Kwon, Min Ji Cho, Nam-Kyung Lee, Jangwook Lee, Jeong Woong Lee, Kyoung-Jin Oh, Kwang-Hee Bae, Jung Hwan Hwang, Jeong-Ki Min, Jong-Gil Park", "journal": "Theranostics. 2023 Jan 22;13(3):1076-1090."}, {"pmid": 18997816, "intro": "This antibody has been successfully used in WB on Human:", "title": "New p53 target, phosphatase of regenerating liver 1 (PRL-1) downregulates p53.", "author": "Min SH, Kim DM, Heo YS, Kim YI, Kim HM, Kim J, Han YM, Kim IC, Yoo OJ.", "journal": "Oncogene. 2009 Jan 29;28(4):545-54."}] |